# Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients

> **NCT02495064** · PHASE4 · UNKNOWN · sponsor: **Yao Liao** · enrollment: 160 (estimated)

## Conditions studied

- Early Radiation Dermatitis

## Interventions

- **DRUG:** Mometasone Furoate Cream

## Key facts

- **NCT ID:** NCT02495064
- **Lead sponsor:** Yao Liao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2016-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02495064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02495064, "Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02495064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*